University of California. San Diego, USA
Scott Letendre, M.D., is Professor of Medicine in Residence in the Division of Infectious Diseases at the University of California, San Diego (UCSD). He graduated from Georgetown University School of Medicine and, following his residency in internal medicine at the Naval Medical Center in San Diego, he completed fellowships in Infectious Disease Medicine at Duke University and in Neurologic HIV Research at UCSD. At UCSD, Dr. Letendre performs translational, patient-oriented research of the central nervous system complications of chronic infections, including HIV, HCV, and CMV. As part of a multidisciplinary research team, he conducts treatment trials of neurocognitively impaired individuals and analyzes their response to therapy as well as studies of the pharmacokinetics of antiretrovirals, the effect of comorbidities, and biomarker correlates of disease. Dr. Letendre is also an investigator in the UCSD unit of the AIDS Clinical Trials Group.
He participates in several international research projects, including projects based in China, India, Zambia, and Romania. Dr
Lluita contra les Infeccions Foundation, Germans Trias i Pujol University Hospital. Barcelona, Spain
Jose A. Muñoz-Moreno is a clinician and researcher at the Lluita contra les Infeccions Foundation, located in the Germans Trias i Pujol University Hospital, in Barcelona (Catalonia, Spain). He earned the Ph.D. degree in Neurosciences in 2012 (Cum Laude), and currently he is also a collaborating professor with the Universitat de Barcelona (UB) and the Universitat Autònoma de Barcelona (UAB).
Muñoz-Moreno is involved in projects that address psychology and the human behaviour associated with HIV infection. In terms of study, he mostly investigates the neurocognitive features of HIV infection, the impact of HIV and antiretroviral treatments on quality of life and emotional status, and adherence to antiretroviral therapy.
Muñoz-Moreno’s recent work particularly focuses on assessment methods to detect HIV-related neurocognitive changes and the current profile of neurocognitive impairment in people living with HIV infection.
St. Mary’s Hospital. London, United Kingdom
Alan Winston is a Professor of HIV and Genitourinary Medicine at Imperial College and Consultant Physician at St. Mary’s Hospital, London. He has an M.D. in antiretroviral clinical pharmacology and his research focuses on non-infectious co-morbidities associated with HIV-disease in the modern antiretroviral era, with a strong focus on central nervous system complications.
Dr. Alan Winston qualified from Glasgow University and undertook training in general medicine and HIV medicine in the UK and Australia. He leads the HIV and GU clinical trials unit at St. Mary’s hospital which runs over 20 studies at one time.
He is the principal clinical investigator on the POPPY study, a cohort study describing the incidence and nature of co-morbidities in HIV.
University of Torino, Italy
He is temporary Assistant Professor at the University of Torino (Department of Medical Sciences, Infectious Diseases). Infectious Diseases Specialist (University of Torino, Italy); Diploma in Tropical Medicine and Hygiene (Mahidol University, Bangkok, Thailand). He is member of the Panel of the Italian Guidelines on the Use of Antiretrovirals and Management of patients living with HIV.
He has experience as a Clinicians in Infectious Diseases and Tropical Medicine (Sudan, Thailand, Burundi); several phase II, III and IV studies in antiretroviral treatment trials.
His main field of interest is the clinical pharmacology and pharmacogenetics of anti-infective agents (antiretroviral, antibiotic, antifungals) and the central nervous system complication of HIV-infection.
Hospital San Rafael. Milan, Italy
She is currently working as senior physician at the Department of Infectious Diseases and responsible of the Neurovirology Research Unit at the Research Division of Immunology, Transplantation and Infectious Diseases of San Raffaele Scientific Institute, Milan, Italy, and as contract Professor of Infectious Diseases at San Raffaele University.
Her research group is mainly involved in studies on HIV Infection of the Central Nervous System, Progressive Multifocal Leukoencephalopathy and other HIV-associated CNS complications.
She is a panel member of the Italian HIV Treatment Guidelines, of the EACS Co-morbidities and of the Opportunistic Infections Guidelines, and of the NIH/CDC/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections.in HIV-Infected Adults and Adolescents.